Baxdrostat

CAS No.

1428652-17-8

MDL No.

N/A

C₂₂H₂₅N₃O₂

363.50

InChI Key

VDEUDSRUMNAXJG-LJQANCHMSA-N

Pack Size	Purity	Price	Availability
1 mg	98%	$33	In Stock
5 mg	98%	$76	In Stock
10 mg	98%	$91	In Stock
25 mg	98%	$179	In Stock
50 mg	98%	$300	In Stock
100 mg	98%	$508	In Stock
250 mg	98%	$961	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

98%

$33

In Stock

5 mg

98%

$76

In Stock

10 mg

98%

$91

In Stock

25 mg

98%

$179

In Stock

50 mg

98%

$300

In Stock

100 mg

98%

$508

In Stock

250 mg

98%

$961

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1428652-17-8
Product Name	Baxdrostat

Associated Conditions

atherosclerosis·hypertension

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

Baxdrostat

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24.

Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers.

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).

Documentation